# STOP-MSU: Stopping Haemorrhage With Tranexamic Acid for Hyperacute Onset Presentation Including Mobile Stroke Units

> **NCT03385928** · PHASE2 · COMPLETED · sponsor: **Neuroscience Trials Australia** · enrollment: 201 (actual)

## Conditions studied

- Intracerebral Haemorrhage

## Interventions

- **DRUG:** Tranexamic Acid
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT03385928
- **Lead sponsor:** Neuroscience Trials Australia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-19
- **Primary completion:** 2023-05-28
- **Final completion:** 2023-05-28
- **Target enrollment:** 201 (ACTUAL)
- **Last updated:** 2023-09-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03385928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03385928, "STOP-MSU: Stopping Haemorrhage With Tranexamic Acid for Hyperacute Onset Presentation Including Mobile Stroke Units". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03385928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*